Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rettino

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Carcinogenesis & Mutagenesis|April 21, 2015
Genome-wide Identification of IRF1 Binding Sites Reveals Extensive Occupancy at Cell Death Associated GenesAlessandro Rettino, Nicole M Clarke
Head and Neck Pathology|October 17, 2024
A Case of Acinic Cell Carcinoma with SYN2::PPARG FusionGrace Dimbleby, Alessandro Rettino, Sanjay Jogai, et al.
American Journal of Physiology. Cell Physiology|August 7, 2009
Identification of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1 gene promoterAlessandro Rettino, Francesca Rafanelli, Giannicola Genovese, et al.
Spine|January 1, 2008
Periprosthetic electrochemical corrosion of titanium and titanium-based alloys as a cause of spinal fusion failureVincenzo Denaro, Nicola Papapietro, Alessandro Sgambato, et al.
Spine|April 23, 2008
Static electromagnetic fields generated by corrosion currents inhibit human osteoblast differentiationVincenzo Denaro, Achille Cittadini, Simona A Barnaba, et al.
Nucleic Acids Research|March 12, 2019
GSK3β-SCFFBXW7α mediated phosphorylation and ubiquitination of IRF1 are required for its transcription-dependent turnoverAlexander J Garvin, Ahmed H A Khalaf, Alessandro Rettino, et al.
Gynecologic Oncology|June 13, 2006
Aberrant expression of alpha-dystroglycan in cervical and vulvar cancerAlessandro Sgambato, Elisabetta Tarquini, Federica Resci, et al.
Cancer Biology & Therapy|December 19, 2007
Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinomaAlessandro Sgambato, Andrea Camerini, Domenico Amoroso, et al.
ESMO Open|October 12, 2017
Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practiceJames L Sherwood, Helen Brown, Alessandro Rettino, et al.
British Journal of Cancer|January 4, 2023
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer careMaria Antonietta Cerone, Tara C Mills, Rowena Sharpe, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Carcinogenesis & Mutagenesis|April 21, 2015
Genome-wide Identification of IRF1 Binding Sites Reveals Extensive Occupancy at Cell Death Associated GenesAlessandro Rettino, Nicole M Clarke
Head and Neck Pathology|October 17, 2024
A Case of Acinic Cell Carcinoma with SYN2::PPARG FusionGrace Dimbleby, Alessandro Rettino, Sanjay Jogai, et al.
American Journal of Physiology. Cell Physiology|August 7, 2009
Identification of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1 gene promoterAlessandro Rettino, Francesca Rafanelli, Giannicola Genovese, et al.
Spine|January 1, 2008
Periprosthetic electrochemical corrosion of titanium and titanium-based alloys as a cause of spinal fusion failureVincenzo Denaro, Nicola Papapietro, Alessandro Sgambato, et al.
Spine|April 23, 2008
Static electromagnetic fields generated by corrosion currents inhibit human osteoblast differentiationVincenzo Denaro, Achille Cittadini, Simona A Barnaba, et al.
Nucleic Acids Research|March 12, 2019
GSK3β-SCFFBXW7α mediated phosphorylation and ubiquitination of IRF1 are required for its transcription-dependent turnoverAlexander J Garvin, Ahmed H A Khalaf, Alessandro Rettino, et al.
Gynecologic Oncology|June 13, 2006
Aberrant expression of alpha-dystroglycan in cervical and vulvar cancerAlessandro Sgambato, Elisabetta Tarquini, Federica Resci, et al.
Cancer Biology & Therapy|December 19, 2007
Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinomaAlessandro Sgambato, Andrea Camerini, Domenico Amoroso, et al.
ESMO Open|October 12, 2017
Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practiceJames L Sherwood, Helen Brown, Alessandro Rettino, et al.
British Journal of Cancer|January 4, 2023
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer careMaria Antonietta Cerone, Tara C Mills, Rowena Sharpe, et al.
Pageof 1